Middle East & Africa Breast Cancer Diagnostics Market Size & Outlook
Middle East & Africa breast cancer diagnostics market, 2018-2030 (US$M)
Related Markets
MEA breast cancer diagnostics market highlights
- The MEA breast cancer diagnostics market generated a revenue of USD 136.0 million in 2024.
- The market is expected to grow at a CAGR of 5.6% from 2025 to 2030.
- In terms of segment, imaging was the largest revenue generating type in 2024.
- Blood Tests is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 136.0 million |
| Market revenue in 2030 | USD 189.0 million |
| Growth rate | 5.6% (CAGR from 2025 to 2030) |
| Largest segment | Imaging |
| Fastest growing segment | Blood Tests |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Imaging, Biopsy, Genomic Tests, Blood Tests |
Other key industry trends
- In terms of revenue, MEA region accounted for 2.5% of the global breast cancer diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,023.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Cancer Diagnostics Market Scope
Breast Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa breast cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer diagnostics market will help companies and investors design strategic landscapes.
Imaging was the largest segment with a revenue share of 55.44% in 2024. Horizon Databook has segmented the Middle East & Africa breast cancer diagnostics market based on imaging, biopsy, genomic tests, blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
The MEA region includes South Africa, Saudi Arabia, and other Middle Eastern & North African countries. The rising prevalence of breast cancer among women in this region is one of the major factors expected to contribute to the market growth.
The growing need for improved healthcare infrastructure and high burden of various diseases are expected to increase the demand for breast cancer diagnostics in the region. In 2022, 71,860.6 cases of breast cancer were diagnosed in South Africa.
In the past few years, countries such as the UAE, Morocco, & South Africa have implemented organized cancer screening programs. Collaborations of various companies with government institutes to supply these tests are also expected to boost the market.
Reasons to subscribe to Middle East & Africa breast cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa breast cancer diagnostics market databook
-
Our clientele includes a mix of breast cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa breast cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa breast cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA breast cancer diagnostics market size, by country, 2018-2030 (US$M)
Middle East & Africa Breast Cancer Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
